PACAP inhibits tumor growth and interferes with clusterin in cervical carcinomas (Q24307847)

1

0 references

Ji-Yeon Lee

2

0 references

Seung Bae Rho

3

0 references

Jong-Soon Choi

4

0 references

Dong-Gi Lee

5

0 references

Sungwhan An

6

0 references

Taejeong Oh

7

0 references

Don-Chan Choi

8

0 references

Seung-Hoon Lee

9

0 references

language of work or name

English

0 references

publication date

20 December 2014

0 references

published in

FEBS Letters

0 references

volume

588

0 references

page(s)

4730-9

0 references

issue

24

0 references

cites work

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Helospectin and pituitary adenylate cyclase activating polypeptide in the human vagina

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Expression of pituitary adenylate cyclase activating peptide in the uterine cervix, lumbosacral dorsal root ganglia and spinal cord of rats during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP+-induced alteration of translational control in Neuro-2a neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Synthesis and functional analyses of nuclear clusterin, a cell death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Overexpression of clusterin in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Modulation of different clusterin isoforms in human colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Clusterin confers paclitaxel resistance in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Apolipoprotein J: structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Clusterin regulates drug-resistance in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Clusterin inhibits apoptosis by interacting with activated Bax

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Phosphorylation and regulation of Raf by Akt (protein kinase B)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Regulation of Raf-Akt Cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

7 January 2021

Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

7 January 2021

PACAP(6-38) inhibits the growth of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

7 January 2021

Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

7 January 2021

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

7 January 2021

Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

7 January 2021

Pituitary adenylate cyclase-activating polypeptide: occurrence and relaxant effect in female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.11.004

7 January 2021